• About
    • About API
    • Leadership & Team
    • Network
      • The API Network
      • Join Us
    • Primary Facilities
      • Biotechnology Business Development Building (BBDC)
      • Drug Development and Innovation Centre
      • Pharmaceutical Analysis Laboratory
      • Health Innovation Hub
  • Services
    • Our Services
    • Engage us
  • Programs
    • Incubator
    • Pfizer ACP Program
    • Life Sciences Investment Summit
    • Life Sciences Venture Coaching
      • Venture Companies and Coaches
    • Health Innovation Hub
      • Research to Revenue Program
  • Life Sciences Week
  • CCDI
  • News
  • Contact
    • Get in touch
    • Media Inquiries
    • Careers
    • Internship Opportunities
Twitter-Logo Linkedin
  • News

News

View all News

Filters
Show All Blog Events News Newsletter

News Release: Newest lupus drug in 60 years discovered in Canada, approved in USA

Posted: Mar 24, 2021 in News

People living with lupus will soon have access to a breakthrough treatment discovered by an Albertan life sciences entrepreneur, who is creating a more globally......

Read More

Nobel Laureate Dr. Michael Houghton joins API Scientific Advisory Board

Posted: Mar 24, 2021 in News

API is thrilled to announce that Nobel Laureate Dr. Michael Houghton has now joined the institute’s Scientific Advisory Board....

Read More

Applied Pharmaceutical Innovation (API) leads coalition establishing significant manufacturing capacity in Alberta

Posted: Mar 23, 2021 in News

The COVID-19 pandemic has further emphasized the need to have manufacturing capacity in Canada not only for vaccines, but to fill drug shortages related to......

Read More

API and CAN announce partnership to support commercialization and innovation in neuroscience

Posted: Mar 17, 2021 in News

Applied Pharmaceutical Innovation (API) is pleased to announce a partnership with Campus Alberta Neuroscience (CAN) to continue to expand innovative research and commercialization opportunities in......

Read More

Q&A with Allan Aginsky, Vice President of Special Projects and Manufacturing

Posted: Mar 12, 2021 in News

We're incredibly fortunate to have Allan Aginsky as Vice President of Special Projects and Manufacturing at API. Learn more about his career and his expertise......

Read More

Dr. Launa Aspeslet discusses team collaboration required to develop voclosporin in Alberta

Posted: Mar 8, 2021 in News

In our latest video interview, Dr. Launa Aspeslet talks about the strength of the life sciences sector in Alberta, as well as the team collaboration......

Read More

IRICoR and API partner to increase drug discovery and commercialization opportunities

Posted: Mar 5, 2021 in News

Alberta-based Applied Pharmaceutical Innovation has partnered with IRICoR, a Quebec-based Centre of Excellence in Commercialization and Research specialized in drug discovery, to expand drug discovery,......

Read More

Q&A: The Importance of Mentorship at API

Posted: Mar 3, 2021 in News

Featuring Dr. Rakesh Bhat, Director of Laboratory Science at API and Post-Doctoral Fellow Dr. Archana Koul. Learn more about them and what they're working on......

Read More

Dr. Michael Houghton, Recent Nobel Prize Winner, on Life Sciences Sector in Alberta

Posted: Mar 2, 2021 in News

Brilliant researchers like Dr. Michael Houghton (recent Nobel Prize Winner) are part of what makes Alberta a phenomenal destination for life sciences companies....

Read More

Alberta’s next biotech star, Hepion Pharmaceuticals, is rising thanks to success of FDA-approved voclosporin, discovered in Edmonton

Posted: Feb 22, 2021 in News

Dr. Robert Foster, CEO of Hepion Pharmaceuticals February 22, 2021 - Edmonton, Alberta A drug discovered in Edmonton has just been approved by the FDA......

Read More

Applied Pharmaceutical Innovation and Antimicrobial Resistance – One Health Consortium partner to bolster the intersection of antimicrobial research and drug development.

Posted: Feb 11, 2021 in News

Applied Pharmaceutical Innovation (API) and Antimicrobial Resistance – One Health Consortium (OHC) have entered a memorandum of understanding to develop the relationship between antimicrobial research......

Read More

API and BioNet Alberta announce partnership to expand collaboration in Alberta’s research and innovation landscape

Posted: Jan 28, 2021 in News

Applied Pharmaceutical Innovation (API) and Bioinformatics Network Alberta (BioNet) have entered a partnership to continue to expand and fuel the growing world-class research landscape present......

Read More
Page 5 of 71234567

API Headquarters

4000 – 10230 Jasper Ave
Edmonton, AB T5J 4P6

Program & Lab Facilities

Biotechnology Business Development Centre
Edmonton Research Park

University of Alberta
Katz Group Centre for Pharmacy and Health Research Edmonton

Life Sciences Innovation Hub
Calgary

  • About
  • Leadership & Team
  • News
  • Contact
  • Services
  • CCDI
  • Incubator
  • Internship Opportunities
Twitter-Logo Linkedin

Copyright © 2019
Applied Pharmaceutical Innovation


API is headquartered in Edmonton, Alberta on Treaty 6 territory and the home of many First Nations, Metis, Inuit and other First Peoples of Canada whose histories, languages, and cultures are integral to the vibrance of communities across Canada.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT